A Phase 2 interventional study of Metformin and Metformin + Fenofibrate in Obesity, sponsored by Solvay Pharmaceuticals. Completed at 3 sites in Finland. Open to participants aged 30 Years to 50 Years. Per ClinicalTrials.gov, last updated 2007-09-03.
Sponsored by Solvay Pharmaceuticals · Phase 2, Interventional, and Treatment
To investigate the effect on body weight of a combination fenofibrate and metformin on top of a moderate balanced calorie-deficit diet.
1,766 studies on the registry are indexed under Weight Loss; 277 are open to participants now.
This study's enrollment of 148 is above the median of 73 across 1,496 interventional studies indexed under Weight Loss.
Browse Weight Loss studies →Solvay Pharmaceuticals is the lead sponsor of 84 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Weight
Waist and hip circumference
This study is completed, as verified in Aug 2007. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Solvay Pharmaceuticals